Insider Trading activities of Ariad Pharmaceuticals Inc insiders. , Part 2

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ariad Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Ariad Pharmaceuticals Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Ariad Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is ARIA. The reporting company's CIK number is 884731.
The total value of stock buying since 2005 is $9,530,946.
The total value of stock sales since 2005 is $52,752,828.
The total value of stock option exercises since 2005 is $11,507,365.


Go to page:  1   2   3   4 

Table 2. Detailed insider stock purchases, sales, and option exercises of Ariad Pharmaceuticals Inc insiders (ARIA) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2015-03-20 Berger Harvey J M D (Chairman & CEO) Option Ex 34,000 .00 0
2015-03-19 Cantor Maria E (SVP, Corporate Affairs and HR) Sale 9,346 9.00 84,114
2015-03-19 Cantor Maria E (SVP, Corporate Affairs and HR) Option Ex 14,375 1.54 22,137
2015-03-19 Haluska Frank (SVP, Clinical R&D, CMO) Option Ex 6,500 .00 0
2015-03-19 Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) Option Ex 8,000 .00 0
2015-03-19 Duvall Martin J (EVP, CCO) Option Ex 8,000 .00 0
2015-03-19 Fitzgerald Edward M (Executive VP, CFO) Option Ex 10,833 .00 0
2015-03-19 Clackson Timothy P (President, R&D, CSO) Sale 20,657 9.00 185,913
2015-03-19 Clackson Timothy P (President, R&D, CSO) Option Ex 31,490 3.78 119,032
2015-03-19 Berstein David L (SVP, Chief IP Counsel) Option Ex 4,750 .00 0
2015-03-19 Berger Harvey J M D (Chairman & CEO) Option Ex 36,000 .00 0
2015-03-16 Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) Sale 34,425 8.62 296,640
2015-03-16 Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) Option Ex 7,500 1.30 9,750
2015-02-20 Clackson Timothy P (President, R&D, CSO) Sale 49,035 8.00 392,280
2015-02-20 Clackson Timothy P (President, R&D, CSO) Option Ex 49,035 3.56 174,319
2015-02-12 Berger Harvey J M D (Chairman & CEO) Buy 12,500 6.90 86,275
2015-02-11 Berger Harvey J M D (Chairman & CEO) Buy 12,500 6.77 84,575
2015-02-02 Cantor Maria E (SVP, Corporate Affairs and HR) Sale 16,134 6.33 102,095
2015-02-02 Cantor Maria E (SVP, Corporate Affairs and HR) Option Ex 29,334 .00 0
2015-02-02 Haluska Frank (SVP, Clinical R&D, CMO) Sale 16,134 6.33 102,112
2015-02-02 Haluska Frank (SVP, Clinical R&D, CMO) Option Ex 29,334 .00 0
2015-02-02 Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) Sale 14,667 6.33 92,827
2015-02-02 Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) Option Ex 29,334 .00 0
2015-02-02 Duvall Martin J (EVP, CCO) Sale 14,667 6.33 92,827
2015-02-02 Duvall Martin J (EVP, CCO) Option Ex 29,334 .00 0
2015-02-02 Fitzgerald Edward M (Executive VP, CFO) Sale 14,667 6.33 92,856
2015-02-02 Fitzgerald Edward M (Executive VP, CFO) Option Ex 29,334 .00 0
2015-02-02 Clackson Timothy P (President, R&D, CSO) Sale 14,667 6.33 92,827
2015-02-02 Clackson Timothy P (President, R&D, CSO) Option Ex 29,334 .00 0
2015-02-02 Berstein David L (SVP, Chief IP Counsel) Sale 14,667 6.33 92,827
2015-02-02 Berstein David L (SVP, Chief IP Counsel) Option Ex 29,334 .00 0
2015-02-02 Berger Harvey J M D (Chairman & CEO) Option Ex 87,000 .00 0
2015-01-23 Berger Harvey J M D (Chairman & CEO) Buy 12,500 6.18 77,250
2015-01-22 Berger Harvey J M D (Chairman & CEO) Buy 12,500 6.16 76,987
2015-01-14 Schlesinger Sarah J. (Director) Buy 1,300 6.25 8,125
2015-01-13 Schlesinger Sarah J. (Director) Buy 1,300 6.97 9,061
2014-12-18 Berger Harvey J M D (Chairman & CEO) Buy 12,500 6.54 81,775
2014-12-17 Schlesinger Sarah J. (Director) Buy 1,300 6.11 7,943
2014-12-17 Berger Harvey J M D (Chairman & CEO) Buy 12,500 6.15 76,875
2014-12-16 Schlesinger Sarah J. (Director) Buy 1,300 6.07 7,891
2014-11-24 Cantor Maria E (SVP, Corporate Affairs and HR) Sale 1,749 7.00 12,243
2014-11-20 Berger Harvey J M D (Chairman & CEO) Buy 12,500 6.15 76,887
2014-11-19 Berger Harvey J M D (Chairman & CEO) Buy 12,500 6.15 76,850
2014-11-12 Schlesinger Sarah J. (Director) Buy 1,300 6.22 8,086
2014-11-11 Schlesinger Sarah J. (Director) Buy 1,300 6.30 8,190
2014-10-16 Berger Harvey J M D (Chairman & CEO) Buy 12,500 5.38 67,312
2014-10-15 Schlesinger Sarah J. (Director) Buy 1,300 5.03 6,539
2014-10-15 Berger Harvey J M D (Chairman & CEO) Buy 12,500 5.10 63,725
2014-10-14 Schlesinger Sarah J. (Director) Buy 1,300 5.07 6,591
2014-09-10 Schlesinger Sarah J. (Director) Buy 1,300 5.75 7,475
2014-09-09 Schlesinger Sarah J. (Director) Buy 1,300 5.93 7,709
2014-09-09 Berstein David L (SVP, GC and Chief IP Officer) Option Ex 7,825 5.23 40,924
2014-09-09 Berger Harvey J M D (Chairman & CEO) Option Ex 150,000 5.23 784,500
2014-09-03 Berger Harvey J M D (Chairman & CEO) Buy 12,500 6.31 78,862
2014-09-02 Cantor Maria E (SVP, Corporate Affairs and HR) Sale 2,696 6.21 16,752
2014-09-02 Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) Sale 56,650 6.22 352,249
2014-09-02 Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) Option Ex 26,250 1.30 34,125
2014-09-02 Fitzgerald Edward M (Executive VP, CFO) Sale 50,000 6.22 310,850
2014-09-02 Fitzgerald Edward M (Executive VP, CFO) Option Ex 50,000 5.23 261,500
2014-09-02 Berger Harvey J M D (Chairman & CEO) Buy 12,500 6.22 77,775
2014-08-15 Denner Alexander J (Director) Buy 850,000 5.83 4,955,500
2014-08-13 Schlesinger Sarah J. (Director) Buy 1,300 5.71 7,423
2014-08-12 Schlesinger Sarah J. (Director) Buy 1,300 5.52 7,175
2014-07-15 Cantor Maria E (SVP, Corporate Affairs and HR) Option Ex 8,000 .00 0
2014-07-15 Haluska Frank (SVP, Clinical R&D, CMO) Option Ex 8,000 .00 0
2014-07-15 Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) Option Ex 8,000 .00 0
2014-07-15 Duvall Martin J (EVP, CCO) Option Ex 2,800 .00 0
2014-07-15 Fitzgerald Edward M (Executive VP, CFO) Option Ex 14,000 .00 0
2014-07-15 Clackson Timothy P (President, R&D, CSO) Option Ex 14,000 .00 0
2014-07-15 Berstein David L (SVP, GC and Chief IP Officer) Option Ex 8,000 .00 0
2014-07-15 Berger Harvey J M D (Chairman & CEO) Option Ex 36,800 .00 0
2014-06-02 Cantor Maria E (SVP, Corporate Affairs and HR) Sale 3,713 6.90 25,612
2014-04-02 Cantor Maria E (SVP, Corporate Affairs and HR) Sale 4,250 8.21 34,909
2014-04-02 Haluska Frank (SVP, Clinical R&D, CMO) Sale 3,400 8.21 27,917
2014-04-02 Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) Sale 2,400 8.22 19,720
2014-04-02 Clackson Timothy P (President, R&D, CSO) Sale 6,500 8.21 53,339
2014-04-02 Berstein David L (SVP, GC and Chief IP Officer) Sale 2,400 8.22 19,718
2014-04-01 Cantor Maria E (SVP, Corporate Affairs and HR) Option Ex 8,500 .00 0
2014-04-01 Haluska Frank (SVP, Clinical R&D, CMO) Option Ex 8,500 .00 0
2014-04-01 Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) Option Ex 6,000 .00 0
2014-04-01 Fitzgerald Edward M (Executive VP, CFO) Option Ex 13,000 .00 0
2014-04-01 Clackson Timothy P (President, R&D, CSO) Option Ex 13,000 .00 0
2014-04-01 Berstein David L (SVP, GC and Chief IP Officer) Option Ex 6,000 .00 0
2014-04-01 Berger Harvey J M D (Chairman & CEO) Option Ex 41,667 .00 0
2014-03-21 Cantor Maria E (SVP, Corporate Affairs and HR) Sale 3,667 7.89 28,928
2014-03-21 Haluska Frank (SVP, Clinical R&D, CMO) Sale 2,400 7.89 18,940
2014-03-21 Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) Sale 2,400 7.89 18,936
2014-03-21 Clackson Timothy P (President, R&D, CSO) Sale 6,667 7.89 52,582
2014-03-21 Berstein David L (SVP, GC and Chief IP Officer) Sale 1,600 7.89 12,630
2014-03-20 Cantor Maria E (SVP, Corporate Affairs and HR) Option Ex 7,333 .00 0
2014-03-20 Haluska Frank (SVP, Clinical R&D, CMO) Option Ex 6,000 .00 0
2014-03-20 Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) Option Ex 6,000 .00 0
2014-03-20 Duvall Martin J (EVP, CCO) Option Ex 1,666 .00 0
2014-03-20 Fitzgerald Edward M (Executive VP, CFO) Option Ex 8,333 .00 0
2014-03-20 Clackson Timothy P (President, R&D, CSO) Option Ex 13,333 .00 0
2014-03-20 Berstein David L (SVP, GC and Chief IP Officer) Option Ex 4,000 .00 0
2014-03-20 Berger Harvey J M D (Chairman & CEO) Option Ex 34,000 .00 0
2014-03-19 Cantor Maria E (SVP, Corporate Affairs and HR) Option Ex 6,500 .00 0
2014-03-19 Haluska Frank (SVP, Clinical R&D, CMO) Option Ex 6,500 .00 0
2014-03-19 Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) Option Ex 8,000 .00 0
2014-03-19 Duvall Martin J (EVP, CCO) Option Ex 8,000 .00 0
2014-03-19 Fitzgerald Edward M (Executive VP, CFO) Option Ex 10,834 .00 0
2014-03-19 Clackson Timothy P (President, R&D, CSO) Option Ex 10,834 .00 0
2014-03-19 Berstein David L (SVP, GC and Chief IP Officer) Option Ex 4,750 .00 0
2014-03-19 Berger Harvey J M D (Chairman & CEO) Option Ex 36,000 .00 0
2013-12-19 Cantor Maria E (SVP, Corporate Affairs) Sale 6,375 5.14 32,767
2013-12-19 Haluska Frank (SVP, Clinical R&D, CMO) Sale 5,100 5.14 26,214
2013-12-19 Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) Sale 3,600 5.15 18,529
2013-12-19 Clackson Timothy P (President, R&D, CSO) Sale 9,750 5.14 50,115
2013-12-19 Berstein David L (Senior VP, Chief IP Officer) Sale 4,500 5.14 23,130
2013-12-18 Cantor Maria E (SVP, Corporate Affairs) Option Ex 12,750 .00 0
2013-12-18 Haluska Frank (SVP, Clinical R&D, CMO) Option Ex 12,750 .00 0
2013-12-18 Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) Option Ex 9,000 .00 0
2013-12-18 Fitzgerald Edward M (Executive VP, CFO) Option Ex 19,500 .00 0
2013-12-18 Clackson Timothy P (President, R&D, CSO) Option Ex 19,500 .00 0
2013-12-18 Berstein David L (Senior VP, Chief IP Officer) Option Ex 9,000 .00 0
2013-12-18 Berger Harvey J M D (Chairman & CEO) Option Ex 62,500 .00 0
2013-11-22 Dodion Pierre F (SVP, Corp. Dev. & Operations) Option Ex 35,250 .00 0
2013-09-19 Duvall Martin J (SVP, Commercial Operations) Option Ex 25,000 .00 0
2013-09-06 Clackson Timothy P (President, R&D, CSO) Sale 8,449 22.00 185,878
2013-08-15 Fitzgerald Edward M (Executive VP, CFO) Option Ex 33,000 3.90 128,700
2013-08-14 Berger Harvey J M D (Chairman & CEO) Sale 66,059 18.44 1,218,194
2013-08-13 Berger Harvey J M D (Chairman & CEO) Sale 52,700 18.23 960,984
2013-07-18 Cantor Maria E (SVP, Corporate Affairs) Sale 8,000 19.79 158,296
2013-07-18 Haluska Frank (SVP, Clinical R&D, CMO) Sale 6,400 19.79 126,643
2013-07-18 Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) Sale 6,400 19.79 126,636
2013-07-18 Keane Raymond T (SVP General Counsel & CCO) Sale 8,000 19.79 158,288
2013-07-18 Dodion Pierre F (SVP, Corp. Dev. & Operations) Sale 6,400 19.79 126,656
2013-07-18 Clackson Timothy P (President, R&D, CSO) Sale 14,000 19.79 277,046
2013-07-18 Berstein David L (Senior VP, Chief IP Officer) Sale 8,000 19.79 158,288
2013-07-17 Berger Harvey J M D (Chairman & CEO) Sale 52,700 19.61 1,033,236
2013-07-16 Berger Harvey J M D (Chairman & CEO) Sale 146,700 20.44 2,998,401
2013-07-15 Cantor Maria E (SVP, Corporate Affairs) Option Ex 16,000 .00 0
2013-07-15 Haluska Frank (SVP, Clinical R&D, CMO) Option Ex 16,000 .00 0
2013-07-15 Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) Option Ex 16,000 .00 0
2013-07-15 Keane Raymond T (SVP General Counsel & CCO) Option Ex 16,000 .00 0
2013-07-15 Dodion Pierre F (SVP, Corp. Dev. & Operations) Option Ex 16,000 .00 0
2013-07-15 Duvall Martin J (SVP, Commercial Operations) Option Ex 5,600 .00 0
2013-07-15 Fitzgerald Edward M (Executive VP, CFO) Option Ex 28,000 .00 0
2013-07-15 Clackson Timothy P (President, R&D, CSO) Option Ex 28,000 .00 0
2013-07-15 Berstein David L (Senior VP, Chief IP Officer) Option Ex 16,000 .00 0
2013-07-15 Berger Harvey J M D (Chairman & CEO) Option Ex 73,600 .00 0
2013-06-19 Berger Harvey J M D (Chairman & CEO) Sale 11,200 18.00 201,622
2013-05-15 Berger Harvey J M D (Chairman & CEO) Sale 39,798 18.18 723,607
2013-05-14 Berger Harvey J M D (Chairman & CEO) Sale 52,700 18.00 948,758
2013-04-17 Berger Harvey J M D (Chairman & CEO) Sale 105,400 18.00 1,897,516
2013-04-02 Cantor Maria E (SVP, Corporate Affairs) Sale 4,250 18.04 76,665
2013-04-02 Haluska Frank (SVP, Clinical R&D, CMO) Sale 3,400 18.04 61,339
2013-04-02 Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) Sale 2,400 18.05 43,327
2013-04-02 Keane Raymond T (SVP General Counsel & CCO) Sale 2,583 18.05 46,625
Go to page:  1   2   3   4 

Insider trading activities including stock purchases, stock sales, and option exercises of ARIA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Ariad Pharmaceuticals Inc (symbol ARIA, CIK number 884731) see the Securities and Exchange Commission (SEC) website.